Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 4,318 shares of the business’s stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $16.89, for a total value of $72,931.02. Following the completion of the transaction, the vice president owned 57,650 shares in the company, valued at $973,708.50. This trade represents a 6.97% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Arteris Price Performance
AIP opened at $17.23 on Friday. The company has a market capitalization of $752.61 million, a PE ratio of -20.76 and a beta of 1.48. Arteris, Inc. has a fifty-two week low of $5.46 and a fifty-two week high of $19.85. The business has a 50-day moving average of $15.41 and a 200-day moving average of $12.14.
Arteris (NASDAQ:AIP – Get Free Report) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.02. The firm had revenue of $17.41 million during the quarter, compared to the consensus estimate of $17.00 million. On average, equities research analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Arteris
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a report on Wednesday, October 8th. Jefferies Financial Group raised shares of Arteris to a “hold” rating in a research report on Tuesday, October 28th. Cowen reaffirmed a “buy” rating on shares of Arteris in a research report on Wednesday, November 5th. Rosenblatt Securities reiterated a “buy” rating and set a $20.00 price target on shares of Arteris in a research note on Monday, December 15th. Finally, TD Cowen raised their price objective on Arteris from $15.00 to $16.50 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $17.50.
View Our Latest Stock Analysis on Arteris
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Articles
- Five stocks we like better than Arteris
- Why Trump and Musk suddenly care about Fort Knox
- Best $19 you’ll spend this year.
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
